Patent Assignment
Reel/Frame 049822/0674
Notice of Grant of Security Interest in Intellectual Property
Recorded: 2019-07-22
Pages: 22
Assignor
MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Executed: 2019-07-19
Assignee
DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
60 WALL STREET, NEW YORK, NEW YORK, 10005
Covered Properties
(131)
Method and System for Determining an Effective Amount of Light Energy to Deliver to Fluids Having Targets for the Light Energy
Patent:
6,219,584 →
Application:
09/350,134 →
Uninterrupted Flow Pump Apparatus and Method
Patent:
6,495,366 →
Application:
09/389,463 →
Low Extracorporeal Volume Treatment System
Patent:
6,793,643 →
Application:
09/556,832 →
Carbon Monoxide Improves Outcomes in Tissue and Organ Transplants and Suppresses Apoptosis
Uninterrupted Flow Pump Apparatus and Method
Method and Apparatus for the Continuous Separation of Biological Fluids into Components
Valve with Smart Handle
Preparation of Metal Mesoporphyrin Halide Compounds
Apparatus for the Continuous Separation of Biological Fluids into Components and Method of Using Same
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Preparation of Metal Mesoporphyrin Compounds
System and Method of Administering a Pharmaceutical Gas to a Patient
Method and Apparatus for Collecting a Blood Component and Performing a Photopheresis Treatment
Phototherapy Compositions and Methods
Method and apparatus for generating nitric oxide for medical use
Apparatus for the Continuous Separation of Biological Fluids into Components and Method of Using Same
Apparatus for the Continuous Separation of Biological Fluids into Components and Method of Using Same
Control System for Driving Fluids Through an Extracorporeal Blood Circuit
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
High-Purity Large-Scale Preparation of Stannsoporfin
Preparation of Metal Mesoporphyrin Compounds
Reduced Dose Intravenous Acetaminophen
Uninterrupted Flow Pump Apparatus and Method
System and Method of Administering a Pharmaceutical Gas to a Patient
Methods and Apparatus for the Administration of Co
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Methods of Reducing the Risk of Occurrence of Pulmonary Edema in Children in Need of Treatment with Inhaled Nitric Oxide
Methods of Reducing the Risk of Occurrence of Pulmonary Edema in Term or Near-Term Neonates in Need of Treatment with Inhaled Nitric Oxide
Preparation of Metal Mesoporphyrin Compounds
High-Purity Large-Scale Preparation of Stannsoporfin
Method and Apparatus for the Manufacture of High Purity Carbon Monoxide
Dosing Regimens and Methods of Treatment Using Carbon Monoxide
Phototherapy Compositions and Methods
Devices And Methods For Engaging Indexed Valve And Pressurized Canister Assembly With Collar And For Linear Actuation By Plunger Assembly Into Fluid Communication With Device For Regulating Drug Delivery
System And Method Of Administering A Pharmaceutical Gas To A Patient
System And Method Of Administering A Pharmaceutical Gas To A Patient
Systems And Methods Of Administering A Pharmaceutical Gas to A Patient
Uninterrupted Flow Pump Apparatus and Method
Methods for Synthesizing Metal Mesoporphyrins
Breathing Apparatus Detection and Purging
Gas Delivery Device and System
Gas Delivery Device and System
System And Method Of Administering A Pharmaceutical Gas To A Patient
Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas
Apparatus and Method for Monitoring Nitric Oxide Delivery
Nitric Oxide Delivery Device
Methods of Distributing a Pharmaceutical Product Comprising Nitric Oxide Gas for Inhalation
Methods for Treating Patients Who Are Candidates for Inhaled Nitric Oxide Treatment
System for Use in Administering Inhaled Nitric Oxide Gas
Application:
13/683,444 →
Publication:
US 2013/0074839
Methods for Treating Hyperbilirubinemia with Stannsoporfin
Application:
13/691,677 →
Publication:
US 2013/0158362
System and Method of Administering a Pharmaceutical Gas to a Patient
Apparatus and Method for Monitoring Nitric Oxide Delivery
Methods Of Administering High Concentrations Of Nitric Oxide
System And Method Of Administering A Pharmaceutical Gas To A Patient
System and Method of Administering a Pharmaceutical Gas to a Patient
System And Method Of Administering A Pharmaceutical Gas To A Patient
High-Purity Large-Scale Preparation of Stannsoporfin
Clinical Decision Support System and Methods
Nitric Oxide Delivery Device
Gas Delivery Device and System
Gas Delivery Device and System
Administration And Monitoring Of Nitric Oxide In Ex Vivo Fluids
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Cannula for Minimizing Dilution of Dosing During Nitric Oxide Delivery
Method and Apparatus for the Manufacture of High Purity Carbon Monoxide
Devices and Methods For Monitoring Oxygenation During Treatment With Delivery Of Nitric Oxide
Application:
14/209,096 →
Publication:
US 2014/0275901
Therapeutic Gas Delivery Device with Pulsed and Continuous Flow Control
Therapeutic Gas Delivery Device With Pulsed And Continuous Flow Control
Methods for Synthesizing Metal Mesoporphyrins
Devices And Methods For Engaging Indexed Valve And Pressurized Canister Assembly With Collar And For Linear Actuation By Plunger Assembly Into Fluid Communication With Device For Regulating Drug Delivery
Method And Apparatus For Generating Nitric Oxide For Medical Use
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Methods of Reducing the Risk of Mortality Associated With a Medical Treatment
Application:
14/313,767 →
Publication:
US 2014/0373836
Methods of Reducing the Risk of Mortality Associated with a Medical Treatment
Application:
14/325,993 →
Publication:
US 2014/0377377
Nitric Oxide Delivery Device
Breathing Apparatus Detection and Purging
Methods of Administering Nitric Oxide to Arterial or Arterialized Blood
High-Purity Large-Scale Preparation of Stannsoporfin
Systems and Methods of Administering a Pharmaceutical Gas to a Patient
Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome in Children
Systems And Methods For Compensating Long Term Sensitivity Drift Of Electrochemical Gas Sensors Exposed To Nitric Oxide
Gas Delivery Device And System
Gas Delivery Device And System For Use In Magnetic Resonance Imaging
Systems And Methods For Manufacturing And Safety Of An NO2-to-NO Reactor Cartridge Used To Deliver NO For Inhalation Therapy To A Patient
Patent:
10,384,031 →
Application:
14/744,298 →
High-Purity Large-Scale Preparation of Stannsoporfin
Methods for Synthesizing Metal Mesoporphyrins
Centrifuge System and Method with Component Tracking
Patent:
10,434,239 →
Application:
15/261,968 →
High-Purity Large-Scale Preparation of Stannsoporfin
Method and Apparatus for the Manufacture of High Purity Carbon Monoxide
Reduced Dose Intravenous Acetaminophen
Apparatus and Method for Filtering Liquid Particles from Inspiratory Gas Flow of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Apparatus and Method for Humidity Conditioning Sample Gas of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Apparatus and Method for Detecting Liquid Level in a Clear or Partially Clear Container
Therapeutic Gas Delivery Device With Pulsed And Continuous Flow Control
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Administration and Monitoring of Nitric Oxide in Ex Vivo Fluids
Support for Centrifuge Tubing
Methods for Synthesizing Metal Mesoporphyrins
Application:
15/603,654 →
Publication:
US 2017/0260217
Apparatus and Method for Monitoring Nitric Oxide Delivery
Devices, Methods, and Systems for Priming, Separating, and Collecting Blood Components
Cannula for Minimizing Dilution of Dosing During Nitric Oxide Delivery
Methods of Reducing the Risk of Mortality Associated With a Medical Treatment
High-Purity Large-Scale Preparation of Stannsoporfin
Devices And Methods For Engaging Indexed Valve And Pressurized Canister Assembly With Collar And For Linear Actuation By Plunger Assembly Into Fluid Communication With Device For Regulating Drug Delivery
Processing Blood
Reduced Dose Intravenous Acetaminophen
Method for Ex-Vivo Expansion of Regulatory T Cells with Enhanced Suppressive Function for Clinical Application in Immune Mediated Diseases
Methods of Administering Nitric Oxide to Arterial or Arterialized Blood
Application:
16/042,031 →
Publication:
US 2018/0339095
Systems and Method for Delivery of Therapeutic Gas to Patients, in Need Thereof, Receiving Breathing Gas from a Ventilator That Varies at Least Pressure and/or Flow Using Enhanced Therapeutic Gas (No) Flow Measurement
Use and Monitoring of Inhaled Nitric Oxide with Left Ventricular Assist Devices
Methods to Improve Organ Viability
Methods for Synthesizing Metal Mesoporphyrins
System And Method Of Administering A Pharmaceutical Gas To A Patient
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Processing Blood
Processing Blood
Systems and Methods for Intelligent Gas Source Management and/or Systems and Methods for Delivery of Therapeutic Gas and/or Enhanced Performance Verification for Therapeutic Gas Delivery
Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome in Children
Gas Delivery Device and System for Use in Magnetic Resonance Imaging
Systems and Method for Delivery of Therapeutic Gas to Patients in Need Thereof Using Enhanced Breathing Circuit Gas (Bcg) Flow Measurement
Systems and Method for Delivery of Therapeutic Gas to Patients in Need Thereof Using Enhanced Breathing Circuit Gas (Bcg) Flow Measurement
High-Purity Large-Scale Preparation of Stannsoporfin
Methods For Treating Hyperbilirubinemia With Stannsoporfin And Phototherapy
Application:
16/300,362 →
Publication:
US 2020/0001109
Therapeutic Gas Delivery Device
Patent:
701,963 →
Application:
29/455,842 →
Therapeutic Gas Delivery Device
Patent:
729,936 →
Application:
29/464,499 →
Therapeutic Gas Delivery Device
Patent:
730,525 →
Application:
29/467,025 →
Therapeutic Gas Delivery Device
Patent:
729,937 →
Application:
29/467,028 →
MRI Compatible Therapeutic Gas Injector Module
Patent:
823,472 →
Application:
29/614,133 →
Self-Contained Gas Sensor Module
Application:
62/774,687 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Nunc Pro Tunc Assignment
May 24, 2019
From: MALLINCKRODT IP UNLIMITED COMPANY
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 049274/0983 →
Nunc Pro Tunc Assignment
May 24, 2019
From: INFACARE PHARMACEUTICAL CORPORATION
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 049274/0943 →
Nunc Pro Tunc Assignment
May 24, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP UNLIMITED COMPANY
Reel/Frame 049274/0954 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP
Reel/Frame 049643/0348 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 049643/0397 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 049643/0282 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 049643/0168 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Patent Security Interests Recorded at Reel 035454, Frame 0768
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0035 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Release of Patent Security Interests Recorded at Reel 049822, Frame 0674
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065609/0454 →
Release of Patent Security Interests Recorded at Reel 044173, Frame 0574
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0128 →
Release of Patent Security Interests Recorded at Reel 036662, Frame 0053
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0503 →
Assignment of Assignor's Interest
Nov 4, 2024
From: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 069127/0749 →
Change of Name
Nov 4, 2024
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
Reel/Frame 069301/0664 →
Release of Security Interests
Dec 3, 2024
From: ACQUIOM AGENCY SERVICES, LLC, AS COLLATERAL AGENT
To: MALLINCKRODT PHARMA IP TRADING LIMITED; STRATATECH CORPORATION; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 069476/0103 →
Patent Security Agreement
Dec 3, 2024
From: SOLARIS IPCO LIMITED
To: NOMURA CORPORATION FUNDING AMERICAS, LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 069476/0380 →
Assignment of Assignor's Interest
Mar 25, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: THERAKOS DEVELOPMENT LIMITED
Reel/Frame 070622/0980 →
Assignment of Assignor's Interest
Mar 25, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: THERAKOS DEVELOPMENT LIMITED
Reel/Frame 070623/0163 →
Security Interest
Aug 1, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 072331/0001 →